Present data showed that administration of jatrorrhizine enabled to reverse expression changes of Bax and Bcl-2 in infarcted myocardium, indicating that jatrorrhizine have potential to suppress cardiomyocyte apoptosis caused by MI. The gene discussed is BCL2; the disease is myocardial infarction.